Patients with Neurostimulators Harness the Power of Community
Online support groups emerge as crucial resources for sleep apnea patients using neurostimulator treatments.
Tag: Respicardia
All
Latest
All
Latest
Highmark Adds Coverage for Remedē System in Patients with Central Sleep Apnea
Highmark Blue Cross Blue Shield and its affiliates will provide coverage for the Respicardia Inc's remedē System implantable therapy for central sleep apnea, effective immediately.
All
LatestSorry, No Posts Found
CMS Grants “New Technology Add-on Payment” to Remedē System for Treatment of Central Sleep Apnea
The Centers for Medicare and Medicaid Services (CMS) has approved a “New Technology Add-On...
Read More
First US Commercial Case Using Remedē for Central Sleep Apnea Completed; Respicardia Appoints CEO
Respicardia Inc, a medical technology company developing therapies that improve cardiovascular...
Read MoreRespicardia Closes $58.5 Million in Financing to Treat Central Sleep Apnea
Respicardia Inc, a private medical technology company, has closed a $58.5 million financing, led by ZOLL Medical Corporation, a manufacturer of medical devices and related software solutions. All of Respicardia’s existing...
Read MoreRespicardia Wins Innovation Award for Central Sleep Apnea Treatment
Respicardia Inc, a developer of implantable therapies to improve respiratory and cardiovascular health, won the Best Innovation of 2014 from Cardiovascular Research Technologies (CRT) and CV Pipeline for the remed? System, an...
Read More